Skip to content
10-Q

Quarterly Report

Oncternal Therapeutics, Inc.

0000950170-24-122383

← back to feed
Filed
Nov 6, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 1, 2024 2.96M sh
Shares Diluted Q3 2024 · Sep 30, 2024 2.96M sh
Shares Diluted Q3 2024 · Sep 30, 2024 2.96M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 2.95M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 2.94M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$20.21M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$25.75M
Short Term Investments Q3 2024 · Sep 30, 2024 $1.5M
Short Term Investments Q3 2024 · Dec 31, 2023 $27.56M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $13.08M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $6.7M
Stockholders Equity Q3 2024 · Sep 30, 2024 $9.15M
Stockholders Equity Q3 2024 · Jun 30, 2024 $15.75M
Stockholders Equity Q3 2024 · Dec 31, 2023 $30.05M
Stockholders Equity restated Q3 2024 · Sep 30, 2023 $37M
Stockholders Equity restated Q3 2024 · Jun 30, 2023 $45.19M
Stockholders Equity Q3 2024 · Dec 31, 2022 $60.97M
Current Liabilities Q3 2024 · Sep 30, 2024 $6.45M
Current Liabilities Q3 2024 · Dec 31, 2023 $5.2M
Total Liabilities Q3 2024 · Sep 30, 2024 $6.45M
Total Liabilities Q3 2024 · Dec 31, 2023 $6.68M
Current Assets Q3 2024 · Sep 30, 2024 $15.45M
Current Assets Q3 2024 · Dec 31, 2023 $36.06M
Total Assets Q3 2024 · Sep 30, 2024 $15.6M
Total Assets Q3 2024 · Dec 31, 2023 $36.73M
Eps Diluted Q3 2024 · Sep 30, 2024 −$2.86
Eps Diluted Q3 2024 · Sep 30, 2024 −$8.58
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$3.35
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$10.32
Eps Basic Q3 2024 · Sep 30, 2024 −$2.86
Eps Basic Q3 2024 · Sep 30, 2024 −$8.58
Eps Basic restated Q3 2024 · Sep 30, 2023 −$3.35
Eps Basic restated Q3 2024 · Sep 30, 2023 −$10.32
Net Income Q3 2024 · Sep 30, 2024 −$8.46M
Net Income Q3 2024 · Sep 30, 2024 −$25.41M
Net Income Q3 2024 · Sep 30, 2023 −$9.86M
Net Income Q3 2024 · Sep 30, 2023 −$30.32M
Operating Income Q3 2024 · Sep 30, 2024 −$8.68M
Operating Income Q3 2024 · Sep 30, 2024 −$26.32M
Operating Income Q3 2024 · Sep 30, 2023 −$10.39M
Operating Income Q3 2024 · Sep 30, 2023 −$32.08M
Revenue Q3 2024 · Sep 30, 2024 $494K
Revenue Q3 2024 · Sep 30, 2024 $1.86M
Revenue Q3 2024 · Sep 30, 2023 $179K
Revenue Q3 2024 · Sep 30, 2023 $488K